Obagi Medical announced Moxie as a strategic partner in the Aesthetics Leadership with Obagi’s Hyaluronic Acid Program. Moxie was selected for its expertise in providing all-in-one software, marketing, coaching, and compliance solutions that help med spa entrepreneurs launch, scale, and optimize their practices with predictable growth, profitability, and a foundation of clinical and operational excellence. Through this real-world evaluation collaboration, Moxie will facilitate a structured assessment of Obagi saypha MagIQ across its network of supported aesthetic practices. The program will leverage Moxie’s strengths in data-driven insights, operational tools, and expert coaching to generate meaningful real-world evidence on the filler’s integration into scalable aesthetic workflows.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WALD:
- Obagi Medical, VIO Med Spa announce collaboration in ALOHA program
- Obagi Medical, Next Health collaborate for ALOHA program
- Obagi Medical, Alpha Aesthetic Partners collaborate for ALOHA program
- Obagi Medical, Platinum Dermatology Partners collaborate for ALOHA program
- Obagi Medical unveils ALOHA Program to launch saypha MagIQ
